Annual Accounts Payable
$16.40 M
+$12.78 M+352.37%
31 December 2023
Summary:
Seelos Therapeutics annual accounts payable is currently $16.40 million, with the most recent change of +$12.78 million (+352.37%) on 31 December 2023. During the last 3 years, it has risen by +$14.52 million (+769.26%). SEEL annual accounts payable is now at all-time high.SEEL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$15.69 M
+$418.00 K+2.74%
30 June 2024
Summary:
Seelos Therapeutics quarterly accounts payable is currently $15.69 million, with the most recent change of +$418.00 thousand (+2.74%) on 30 June 2024. Over the past year, it has increased by +$6.37 million (+68.30%). SEEL quarterly accounts payable is now -4.37% below its all-time high of $16.40 million, reached on 31 December 2023.SEEL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +352.4% | +68.3% |
| 3 y3 years | +769.3% | +361.2% |
| 5 y5 years | +6880.0% | +748.8% |
SEEL Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +868.9% | -4.4% | +826.5% |
| 5 y | 5 years | at high | +6880.0% | -4.4% | +4318.6% |
| alltime | all time | at high | >+9999.0% | -4.4% | >+9999.0% |
Seelos Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $15.69 M(+2.7%) |
| Mar 2024 | - | $15.27 M(-6.9%) |
| Dec 2023 | $16.40 M(+352.4%) | $16.40 M(+76.0%) |
| Sept 2023 | - | $9.32 M(+44.8%) |
| June 2023 | - | $6.44 M(+7.9%) |
| Mar 2023 | - | $5.96 M(+64.5%) |
| Dec 2022 | $3.63 M(+114.2%) | $3.63 M(-39.1%) |
| Sept 2022 | - | $5.95 M(+158.1%) |
| June 2022 | - | $2.31 M(+8.4%) |
| Mar 2022 | - | $2.13 M(+25.6%) |
| Dec 2021 | $1.69 M(-10.3%) | $1.69 M(-50.2%) |
| Sept 2021 | - | $3.40 M(+227.6%) |
| June 2021 | - | $1.04 M(-36.2%) |
| Mar 2021 | - | $1.63 M(-13.7%) |
| Dec 2020 | $1.89 M(+137.1%) | $1.89 M(+431.5%) |
| Sept 2020 | - | $355.00 K(-43.7%) |
| June 2020 | - | $630.00 K(-80.8%) |
| Mar 2020 | - | $3.28 M(+312.2%) |
| Dec 2019 | $796.00 K(+238.7%) | $796.00 K(-56.9%) |
| Sept 2019 | - | $1.85 M(+80.3%) |
| June 2019 | - | $1.02 M(-57.7%) |
| Mar 2019 | - | $2.42 M(+930.2%) |
| Dec 2018 | $235.00 K(+305.2%) | $235.00 K(-27.0%) |
| Sept 2018 | - | $322.00 K(-69.4%) |
| June 2018 | - | $1.05 M(+206.4%) |
| Mar 2018 | - | $344.00 K(+493.1%) |
| Dec 2017 | $58.00 K(-92.4%) | $58.00 K(-77.9%) |
| Sept 2017 | - | $262.00 K(+87.1%) |
| June 2017 | - | $140.00 K(-71.1%) |
| Mar 2017 | - | $485.00 K(-36.4%) |
| Dec 2016 | $763.00 K(-51.7%) | $763.00 K(-46.8%) |
| Sept 2016 | - | $1.43 M(-10.4%) |
| June 2016 | - | $1.60 M(+46.1%) |
| Mar 2016 | - | $1.10 M(-30.6%) |
| Dec 2015 | $1.58 M(+83.7%) | $1.58 M(+278.9%) |
| Sept 2015 | - | $417.00 K(-6.5%) |
| June 2015 | - | $446.00 K(-49.3%) |
| Mar 2015 | - | $880.00 K(+2.3%) |
| Dec 2014 | $860.00 K(-7.1%) | $860.00 K(-29.6%) |
| Sept 2014 | - | $1.22 M(+8.2%) |
| June 2014 | - | $1.13 M(+13.7%) |
| Mar 2014 | - | $992.00 K(+7.1%) |
| Dec 2013 | $926.00 K | $926.00 K(+50.6%) |
| Sept 2013 | - | $615.00 K(-57.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2013 | - | $1.46 M(-21.2%) |
| Mar 2013 | - | $1.85 M(-18.8%) |
| Dec 2012 | $2.28 M(+116.4%) | $2.28 M(+12.0%) |
| Sept 2012 | - | $2.03 M(+192.7%) |
| June 2012 | - | $694.80 K(-5.8%) |
| Mar 2012 | - | $737.50 K(-29.9%) |
| Dec 2011 | $1.05 M(+69.2%) | $1.05 M(-19.6%) |
| Sept 2008 | - | $1.31 M(+118.4%) |
| June 2008 | - | $598.80 K(-0.9%) |
| Mar 2008 | - | $604.20 K(-2.8%) |
| Dec 2007 | $621.70 K(+5.8%) | $621.70 K(-5.0%) |
| Sept 2007 | - | $654.60 K(+27.5%) |
| June 2007 | - | $513.40 K(-26.0%) |
| Mar 2007 | - | $693.60 K(+18.0%) |
| Dec 2006 | $587.70 K(-14.9%) | $587.70 K(-18.4%) |
| Sept 2006 | - | $720.10 K(+30.5%) |
| June 2006 | - | $551.90 K(-26.2%) |
| Mar 2006 | - | $747.80 K(+8.3%) |
| Dec 2005 | $690.30 K(-39.9%) | $690.30 K(-46.8%) |
| Sept 2005 | - | $1.30 M(+14.5%) |
| June 2005 | - | $1.13 M(+6.0%) |
| Mar 2005 | - | $1.07 M(-6.9%) |
| Dec 2004 | $1.15 M(+48.4%) | $1.15 M(-23.6%) |
| Sept 2004 | - | $1.50 M(+14.2%) |
| June 2004 | - | $1.32 M(+50.6%) |
| Mar 2004 | - | $873.90 K(+13.0%) |
| Dec 2003 | $773.50 K(-84.1%) | $773.50 K(-33.4%) |
| Sept 2003 | - | $1.16 M(-43.4%) |
| June 2003 | - | $2.05 M(-52.4%) |
| Mar 2003 | - | $4.30 M(-11.7%) |
| Dec 2002 | $4.87 M(+122.1%) | $4.87 M(+264.8%) |
| Sept 2002 | - | $1.34 M(-34.2%) |
| June 2002 | - | $2.03 M(+37.8%) |
| Mar 2002 | - | $1.47 M(-32.9%) |
| Dec 2001 | $2.19 M(+76.2%) | $2.19 M(+92.4%) |
| Sept 2001 | - | $1.14 M(+3.2%) |
| June 2001 | - | $1.11 M(-14.1%) |
| Mar 2001 | - | $1.29 M(+3.3%) |
| Dec 2000 | $1.25 M(+107.6%) | $1.25 M(+242.9%) |
| Sept 2000 | - | $363.20 K(+71.2%) |
| June 2000 | - | $212.10 K(-49.8%) |
| Mar 2000 | - | $422.80 K |
| Dec 1999 | $600.00 K(-1.4%) | - |
| Dec 1997 | $608.30 K | - |
FAQ
- What is Seelos Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Seelos Therapeutics?
- What is Seelos Therapeutics annual accounts payable year-on-year change?
- What is Seelos Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly accounts payable year-on-year change?
What is Seelos Therapeutics annual accounts payable?
The current annual accounts payable of SEEL is $16.40 M
What is the all time high annual accounts payable for Seelos Therapeutics?
Seelos Therapeutics all-time high annual accounts payable is $16.40 M
What is Seelos Therapeutics annual accounts payable year-on-year change?
Over the past year, SEEL annual accounts payable has changed by +$12.78 M (+352.37%)
What is Seelos Therapeutics quarterly accounts payable?
The current quarterly accounts payable of SEEL is $15.69 M
What is the all time high quarterly accounts payable for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly accounts payable is $16.40 M
What is Seelos Therapeutics quarterly accounts payable year-on-year change?
Over the past year, SEEL quarterly accounts payable has changed by +$6.37 M (+68.30%)